RPL32P13

Across TCGA pan-cancer cohorts, RPL32P13 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL32P13’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RPL32P13 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL32P13 is over-expressed in tumor, although a few such as UCEC show the opposite, repressed pattern.

UCEC, PRAD, and LUAD are the cancer types where RPL32P13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	−0.390	.002	2	view →
PRAD	All	All	+0.077	.023	2	view →
LUAD	All	All	+0.074	.042	2	view →
COAD	All	All	+0.161	.034	1	view →
KIRC	Male	All	+0.050	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPL32P13–UCEC

Open the UCEC breakdown →